|
End-of-day quote
Taiwan S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 45.95 TWD | -1.18% |
|
-0.43% | -22.51% |
| Market Cap | 5.53B 169M 152M 140M 126M 236M 16.08B 241M 1.66B 668M 8.46B 636M 622M 26.67B | P/E 2024 |
52.9x | P/E 2025 | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.64B 204M 182M 168M 152M 284M 19.33B 289M 2B 803M 10.17B 764M 748M 32.06B | EV / Sales 2024 |
2x | EV / Sales 2025 | 1.7x |
| Free-Float |
78.86% | Yield 2024 |
4.36% | Yield 2025 | 5.06% |
| 1 day | -1.18% | ||
| 1 week | -0.43% | ||
| 1 month | -6.13% | ||
| 3 months | -9.37% | ||
| 6 months | -15.06% | ||
| Current year | -22.51% |
| 1 week | 45.25 |  | 46.75 |
| 1 month | 45.25 | | 49.15 |
| Current year | 45 | | 62.5 |
| 1 year | 45 | | 67.4 |
| 3 years | 45 | | 121 |
| 5 years | 44.2 | | 121 |
| 10 years | 29.75 | | 121 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
CEO | Chief Executive Officer | - | 01/01/1996 |
Yue Chen Lo
DFI | Director of Finance/CFO | - | 14/04/2003 |
Chin Yuan Lin
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
CHM | Chairman | - | 01/01/1996 |
Che Jen Chuang
BRD | Director/Board Member | - | 18/06/2012 |
Hung Min Hsieh
BRD | Director/Board Member | - | 28/08/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.18% | -0.43% | -25.89% | -46.51% | 169M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.76% | +5.27% | +39.34% | +71.45% | 426.21B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.73B 145M 130M 119M 108M 202M 13.77B 206M 1.42B 572M 7.24B 544M 533M 22.84B | 4.85B 149M 133M 122M 111M 207M 14.12B 211M 1.46B 586M 7.43B 558M 546M 23.42B |
| Net income | 157M 4.82M 4.32M 3.97M 3.6M 6.72M 458M 6.85M 47.35M 19.01M 241M 18.09M 17.7M 759M | 441M 13.52M 12.11M 11.14M 10.09M 18.86M 1.28B 19.22M 133M 53.31M 675M 50.73M 49.65M 2.13B |
| Net Debt | 1.2B 36.65M 32.83M 30.19M 27.36M 51.14M 3.48B 52.1M 360M 145M 1.83B 138M 135M 5.77B | 1.12B 34.18M 30.62M 28.16M 25.52M 47.7M 3.25B 48.59M 336M 135M 1.71B 128M 126M 5.38B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | NT$45.95 | -1.18% | 499,428 |
| 29/10/26 | NT$46.50 | +1.09% | 355,435 |
| 28/10/26 | NT$46.00 | +0.22% | 315,298 |
| 27/10/26 | NT$45.90 | -0.54% | 326,813 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4746 Stock
Select your edition
All financial news and data tailored to specific country editions
